Elevated Uric Acid Levels Predict Allograft Vasculopathy in Cardiac Transplant Recipients

Elevated UA confers an increased risk of CAV. This association may be causal, with pathophysiologic implications for the role of hyperuricemia in allograft failure and, if substantiated, could have clinical implications for the use of xanthine oxidase inhibitors in cardiac transplant recipients.